ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 171 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2019. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $225,437 | -59.2% | 4,887 | -63.4% | 0.06% | -70.7% |
Q3 2022 | $553,000 | +41.1% | 13,355 | +147.7% | 0.22% | -1.4% |
Q1 2022 | $392,000 | -23.3% | 5,392 | +0.5% | 0.22% | -53.1% |
Q2 2021 | $511,000 | +150.5% | 5,364 | +66.9% | 0.46% | +244.4% |
Q2 2019 | $204,000 | -61.6% | 3,214 | -71.9% | 0.14% | -12.9% |
Q4 2017 | $531,000 | +149.3% | 11,453 | +186.3% | 0.16% | +158.3% |
Q3 2017 | $213,000 | -27.1% | 4,000 | +53.8% | 0.06% | -73.5% |
Q4 2015 | $292,000 | – | 2,600 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iguana Healthcare Management, LLC | 75,000 | $5,084,000 | 2.52% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,237,825 | $83,900,000 | 1.18% |
CAPITAL INTERNATIONAL LTD /CA/ | 206,718 | $14,011,000 | 0.91% |
Cormorant Asset Management, LP | 75,000 | $5,084,000 | 0.74% |
Capital International Sarl | 107,450 | $7,283,000 | 0.63% |
Rock Springs Capital Management LP | 159,750 | $10,828,000 | 0.62% |
Opus Point Partners Management, LLC | 12,201 | $827,000 | 0.61% |
Hood River Capital Management LLC | 109,629 | $7,431,000 | 0.56% |
Aureus Asset Management, LLC | 50,740 | $2,927,000 | 0.51% |
ROCKEFELLER FINANCIAL SERVICES INC | 374,663 | $25,395,000 | 0.51% |